Chloe Walton

463 total citations
13 papers, 308 citations indexed

About

Chloe Walton is a scholar working on Speech and Hearing, Physiology and Clinical Psychology. According to data from OpenAlex, Chloe Walton has authored 13 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Speech and Hearing, 7 papers in Physiology and 3 papers in Clinical Psychology. Recurrent topics in Chloe Walton's work include Voice and Speech Disorders (7 papers), Dysphagia Assessment and Management (7 papers) and Tracheal and airway disorders (3 papers). Chloe Walton is often cited by papers focused on Voice and Speech Disorders (7 papers), Dysphagia Assessment and Management (7 papers) and Tracheal and airway disorders (3 papers). Chloe Walton collaborates with scholars based in Australia, United Kingdom and Malaysia. Chloe Walton's co-authors include Paul Carding, Helen Blackshaw, Erin Conway, Biju Jose, Robert E. J. Ryder, Thozhukat Sathyapalan, Nithya Sukumar, Alan S. Rigby, Stephen L. Atkin and Elizabeth Cardell and has published in prestigious journals such as Cancer Research, Clinical Microbiology and Infection and The Laryngoscope.

In The Last Decade

Chloe Walton

13 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chloe Walton Australia 10 151 119 108 79 54 13 308
Claudia Boettcher Germany 8 26 0.2× 36 0.3× 485 4.5× 46 0.6× 26 0.5× 28 607
Jui‐Sheng Hung Taiwan 13 48 0.3× 89 0.7× 7 0.1× 64 0.8× 20 0.4× 68 512
Audrey Austin United States 5 23 0.2× 68 0.6× 157 1.5× 73 0.9× 16 0.3× 8 309
A. Abdelghani Tunisia 10 141 0.9× 11 0.1× 8 0.1× 174 2.2× 24 0.4× 65 317
Pierre Henri Ducluzeau France 8 116 0.8× 6 0.1× 62 0.6× 27 0.3× 6 0.1× 13 244
Juliane Rothermel Germany 10 90 0.6× 5 0.0× 112 1.0× 37 0.5× 65 1.2× 18 392
Esther Bollow Germany 12 22 0.1× 36 0.3× 189 1.8× 8 0.1× 23 0.4× 27 354
Stéphanie Woerner United States 9 50 0.3× 97 0.8× 632 5.9× 9 0.1× 71 1.3× 15 773
Ryoko Fujiwara Japan 11 204 1.4× 7 0.1× 91 0.8× 6 0.1× 52 1.0× 21 351
Lulu K. Lee United States 11 123 0.8× 4 0.0× 39 0.4× 71 0.9× 15 0.3× 17 314

Countries citing papers authored by Chloe Walton

Since Specialization
Citations

This map shows the geographic impact of Chloe Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Walton more than expected).

Fields of papers citing papers by Chloe Walton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Walton. The network helps show where Chloe Walton may publish in the future.

Co-authorship network of co-authors of Chloe Walton

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Walton. A scholar is included among the top collaborators of Chloe Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Walton. Chloe Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Khanyile, Richard, Graham Cohen, Chloe Walton, et al.. (2025). Abstract CT035: Pharmacokinetics (PK), safety, and tolerability of pembrolizumab with berahyaluronidase alfa administered subcutaneously Q3W in participants with advanced melanoma. Cancer Research. 85(8_Supplement_2). CT035–CT035. 1 indexed citations
2.
Wenke, Rachel, Chloe Walton, Catherine Madill, et al.. (2021). Effectiveness of Intensive Voice Therapy Versus Weekly Therapy for Muscle Tension Dysphonia: A Noninferiority Randomised Controlled Trial With Nested Focus Group. Journal of Voice. 37(3). 466.e17–466.e34. 12 indexed citations
3.
Walton, Chloe, et al.. (2021). A Comparison of Voice and Psychotherapeutic Treatments for Adults With Functional Voice Disorders: A Systematic Review. Journal of Voice. 38(2). 542.e9–542.e27. 3 indexed citations
4.
Walton, Chloe, et al.. (2018). Voice Outcome Measures for Adult Patients With Unilateral Vocal Fold Paralysis: A Systematic Review. The Laryngoscope. 129(1). 187–197. 21 indexed citations
5.
Walton, Chloe, et al.. (2018). Perspectives on voice treatment for unilateral vocal fold paralysis. Current Opinion in Otolaryngology & Head & Neck Surgery. 26(3). 157–161. 31 indexed citations
6.
Reddihough, Dinah, et al.. (2018). Behavioural interventions to treat drooling in children with neurodisability: a systematic review. Developmental Medicine & Child Neurology. 61(1). 39–48. 18 indexed citations
7.
8.
Walton, Chloe, Erin Conway, Helen Blackshaw, & Paul Carding. (2016). Unilateral Vocal Fold Paralysis: A Systematic Review of Speech-Language Pathology Management. Journal of Voice. 31(4). 509.e7–509.e22. 41 indexed citations
9.
Wenke, Rachel, et al.. (2014). Is More Intensive Better? Client and Service Provider Outcomes for Intensive Versus Standard Therapy Schedules for Functional Voice Disorders. Journal of Voice. 28(5). 652.e31–652.e43. 32 indexed citations
10.
Atkin, Stephen L., et al.. (2011). The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes. Diabetic Medicine. 28(5). 519–524. 32 indexed citations
11.
Jose, Biju, et al.. (2011). Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit. Diabetes Research and Clinical Practice. 93(2). e87–e91. 21 indexed citations
12.
Jose, Biju, Nithya Sukumar, Thozhukat Sathyapalan, et al.. (2011). Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit *. Diabetes Obesity and Metabolism. 13(8). 703–710. 78 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Boettcher Breakdown of academic impact, for papers by Jui‐Sheng Hung Breakdown of academic impact, for papers by Audrey Austin Breakdown of academic impact, for papers by A. Abdelghani Breakdown of academic impact, for papers by Pierre Henri Ducluzeau Breakdown of academic impact, for papers by Juliane Rothermel Breakdown of academic impact, for papers by Esther Bollow Breakdown of academic impact, for papers by Stéphanie Woerner Breakdown of academic impact, for papers by Ryoko Fujiwara Breakdown of academic impact, for papers by Lulu K. Lee
Rankless by CCL
2026